{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:06:24Z","timestamp":1790701584650,"version":"4.1.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.phrs.2020.104786","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:47:20Z","timestamp":1586346440000},"page":"104786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?"],"prefix":"10.1016","volume":"156","author":[{"given":"Federico","family":"Cucchiara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pasqualetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Sean","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romano","family":"Danesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.104786_bib0005","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0010","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","author":"Ostrom","year":"2015","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0015","first-page":"4655","article-title":"Recent trends in epidemiology of brain metastases: an overview","volume":"32","author":"Tabouret","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/neuonc\/now127","article-title":"Updates in the management of brain metastases","volume":"18","author":"Arvold","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.phrs.2020.104786_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nec.2010.08.007","article-title":"Epidemiology of metastatic brain tumors","volume":"22","author":"Fox","year":"2011","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.phrs.2020.104786_bib0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0040","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1200\/JCO.2009.24.6314","article-title":"Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer","volume":"28","author":"Graesslin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1042-3680(18)30365-6","article-title":"Demographics of brain metastasis","volume":"7","author":"Johnson","year":"1996","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.phrs.2020.104786_bib0050","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0055","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2020.104786_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fsurg.2016.00030","article-title":"The current and future treatment of brain metastases","volume":"3","author":"Hardesty","year":"2016","journal-title":"Front. Surg."},{"key":"10.1016\/j.phrs.2020.104786_bib0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0070","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.canep.2016.04.007","article-title":"Descriptive epidemiology of brain and central nervous system cancers in Central and South America","volume":"44S","author":"Pi\u00f1eros","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.phrs.2020.104786_bib0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"Mcneill","year":"2016","journal-title":"Neurol. Clin. NA"},{"key":"10.1016\/j.phrs.2020.104786_bib0080","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2020.104786_bib0085","series-title":"Epidemiology of Pediatric Central Nervous System Tumors BT - Brain Tumors in Children","first-page":"1","author":"Vitanza","year":"2018"},{"key":"10.1016\/j.phrs.2020.104786_bib0090","series-title":"Pathology of Tumours of the Nervous System","author":"Ironside","year":"1989"},{"key":"10.1016\/j.phrs.2020.104786_bib0095","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0100","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2020.104786_bib0105","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain tumors","volume":"131","author":"McFaline-Figueroa","year":"2018","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2020.104786_bib0110","series-title":"Handb. Clin. Neurol.","article-title":"Brain metastases","author":"Perez-Larraya","year":"2014"},{"key":"10.1016\/j.phrs.2020.104786_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/157015912800604470","article-title":"Brain tumor-related epilepsy","author":"Maschio","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0120","first-page":"267","article-title":"Epilepsy and brain tumors","author":"Englot","year":"2016","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0125","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.wnl.0000285084.93652.43","article-title":"Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review)","volume":"69","author":"Krumholz","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2020.104786_bib0130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.seizure.2010.07.001","article-title":"Early presentation of de novo high grade glioma with epileptic seizures: electroclinical and neuroimaging findings","volume":"19","author":"Rossi","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.phrs.2020.104786_bib0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-009-0056-5","article-title":"The role of prophylactic anticonvulsants in the management of brain metastases : a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Mikkelsen","year":"2010","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11910-017-0777-3","article-title":"Brain tumor-related epilepsy: a current review of the etiologic basis and diagnostic and treatment approaches","volume":"17","author":"Politsky","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.phrs.2020.104786_bib0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000052089","article-title":"Seizure disorders in patients with brain tumors","volume":"45","author":"Liigant","year":"2001","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","article-title":"Seizure prognosis in brain tumors: new insights and evidence-based management","author":"Vecht","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.phrs.2020.104786_bib0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.seizure.2011.12.016","article-title":"The pathogenesis of tumor-related epilepsy and its implications for clinical treatment","volume":"21","author":"You","year":"2012","journal-title":"Seizure Eur. J. Epilepsy."},{"issue":"70","key":"10.1016\/j.phrs.2020.104786_bib0160","article-title":"Brain tumor-related epilepsy: a current review of the etiologic basis and diagnostic and treatment approaches","volume":"17","author":"Politsky","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.phrs.2020.104786_bib0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/01616412.1988.11739825","article-title":"Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy","volume":"10","author":"Bateman","year":"1988","journal-title":"Neurol. Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0170","first-page":"4383","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0404.2004.00355.x","article-title":"Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis","volume":"111","author":"Schaller","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.phrs.2020.104786_bib0180","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-07-2034","article-title":"Autocrine glutamate signaling promotes glioma cell invasion","volume":"67","author":"Lyons","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0185","first-page":"449","article-title":"Quantitative analysis of experimental peritumoral edema in cats","volume":"52","author":"Hossmann","year":"1990","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3181\/0711-MR-308","article-title":"An unexpected role for ion channels in brain tumor metastasis","volume":"233","author":"Sontheimer","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.phrs.2020.104786_bib0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s004010000180","article-title":"Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme","volume":"100","author":"Liebner","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2020.104786_bib0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000151433","article-title":"Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity","volume":"82","author":"Chi","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.phrs.2020.104786_bib0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood-brain barrier: structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s004010000305","article-title":"Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex","volume":"101","author":"Aronica","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2020.104786_bib0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10143-009-0191-7","article-title":"Brain tumors and epilepsy: pathophysiology of peritumoral changes","volume":"32","author":"Shamji","year":"2009","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.phrs.2020.104786_bib0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2020.104786_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7597.2005.05101.x","article-title":"Inflammation and epilepsy","volume":"5","author":"Vezzani","year":"2005","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.phrs.2020.104786_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0235","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000097189","article-title":"Effects of interleukin-2 on various models of experimental epilepsy in DBA\/2 mice","volume":"1","author":"De Sarro","year":"1994","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.phrs.2020.104786_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1991.tb16974.x","article-title":"Behavioral and electrocortical spectrum power effects after microinfusion of lymphokines in several areas of the rat brain","volume":"621","author":"Nistico","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib0250","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0255","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.mayocp.2018.06.019","article-title":"Onco-epilepsy: more than tumor and seizures","volume":"93","author":"Tatum","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2020.104786_bib0260","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022434","article-title":"Role of astrocytes in epilepsy","volume":"5","author":"Coulter","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.phrs.2020.104786_bib0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1874082001004010093","article-title":"Adenosine dysfunction and adenosine kinase in epileptogenesis","volume":"4","author":"Boison","year":"2010","journal-title":"Open Neurosci. J."},{"key":"10.1016\/j.phrs.2020.104786_bib0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1470-2045(01)00622-2","article-title":"The seed and soil hypothesis: vascularisation and brain metastases","volume":"3","author":"Fidler","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0275","first-page":"4959","article-title":"Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis","volume":"60","author":"Yano","year":"2000","journal-title":"Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.phrs.2020.104786_bib0280","first-page":"89","article-title":"Brain metastasis: role of trophic, autocrine, and paracrine factors in tumor invasion and colonization of the central nervous system","volume":"213","author":"Nicolson","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.phrs.2020.104786_bib0285","first-page":"4767","article-title":"Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase","volume":"60","author":"Marchetti","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0290","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2020.104786_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom7020034","article-title":"The process and regulatory components of inflammation in brain oncogenesis","volume":"7","author":"Mostofa","year":"2017","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2020.104786_bib0300","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tins.2007.08.007","article-title":"Neuronal \u201cOn\u201d and \u201cOff\u201d signals control microglia","volume":"30","author":"Biber","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib0305","first-page":"31","article-title":"The role of inflammation in brain cancer","volume":"Vol. 816","author":"Sowers","year":"2014"},{"key":"10.1016\/j.phrs.2020.104786_bib0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14728214.2012.679929","article-title":"Recent developments on immunotherapy for brain cancer","volume":"17","author":"Wainwright","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.phrs.2020.104786_bib0315","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1528-1157.1981.tb04108.x","article-title":"Kynurenines and seizures","volume":"22","author":"Lapin","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0320","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-\u03b2 signaling suppression","volume":"75","author":"Bar-Klein","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0325","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/MN:29:1:61","article-title":"Ion channels and amino acid transporters support the growth and invasion of primary brain tumors","volume":"29","author":"Sontheimer","year":"2004","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2020.104786_bib0330","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s004010050439","article-title":"Perilesional neurochemical changes in focal epilepsies","volume":"91","author":"Wolf","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2020.104786_bib0335","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.67.12_suppl_4.S10","article-title":"Optimizing therapy of seizures in patients with brain tumors","volume":"67","author":"Vecht","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2020.104786_bib0340","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission","volume":"52","author":"Blumcke","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0345","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00702-014-1182-6","article-title":"Glutamate and its receptors in cancer","volume":"121","author":"Stepulak","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2020.104786_bib0350","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2008.05301.x","article-title":"A role for glutamate in growth and invasion of primary brain tumors","volume":"105","author":"Sontheimer","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.104786_bib0355","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.0305-1846.2001.00314.x","article-title":"Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy","volume":"27","author":"Aronica","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.phrs.2020.104786_bib0360","doi-asserted-by":"crossref","first-page":"14687","DOI":"10.1073\/pnas.251531398","article-title":"Underediting of glutamate receptor GluR-B mRNA in malignant gliomas","volume":"98","author":"Maas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2020.104786_bib0365","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1528-1167.2007.00925.x","article-title":"Differential cellular gene expression in ganglioglioma","volume":"48","author":"Samadani","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0370","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuroscience.2007.10.036","article-title":"Gene expression profile analysis of epilepsy-associated gangliogliomas","volume":"151","author":"Aronica","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2020.104786_bib0375","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1093\/brain\/awn233","article-title":"Array analysis of epilepsy-associated gangliogliomas reveals expression patterns related to aberrant development of neuronal precursors","volume":"131","author":"Fassunke","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2020.104786_bib0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eplepsyres.2006.12.002","article-title":"Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex","volume":"74","author":"Aronica","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0385","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/wmts.21","article-title":"mGlu receptors and cancerous growth","volume":"1","author":"Teh","year":"2013","journal-title":"Wiley Interdiscip. Rev. Membr. Transp. Signal."},{"key":"10.1016\/j.phrs.2020.104786_bib0390","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2020.104786_bib0395","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/glia.21113","article-title":"Glutamate and the biology of gliomas","volume":"59","author":"de Groot","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2020.104786_bib0400","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10585-009-9277-4","article-title":"Cancer cell lines release glutamate into the extracellular environment","volume":"26","author":"Seidlitz","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.phrs.2020.104786_bib0405","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm0901-994","article-title":"Excitotoxic destruction facilitates brain tumor growth","volume":"7","author":"Rothstein","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2020.104786_bib0410","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1073\/pnas.091113598","article-title":"Glutamate antagonists limit tumor growth","volume":"98","author":"Rzeski","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib0415","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1073\/pnas.0507679102","article-title":"NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth","volume":"102","author":"Stepulak","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib0420","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4161\/cbt.6.12.4965","article-title":"AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth","volume":"6","author":"Stepulak","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phrs.2020.104786_bib0425","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.25898","article-title":"Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling","volume":"129","author":"Herner","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0430","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1046\/j.1471-4159.2000.0741931.x","article-title":"Glutamate-stimulated activation of DNA synthesis via mitogen-activated protein kinase in primary astrocytes: involvement of protein kinase C and related adhesion focal tyrosine kinase","volume":"74","author":"Schinkmann","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.104786_bib0435","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4161\/cbt.9.6.10898","article-title":"Glutamate receptors in pediatric tumors of the central nervous system","volume":"9","author":"Brocke","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phrs.2020.104786_bib0440","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00418-009-0613-1","article-title":"Expression of glutamate receptor subunits in human cancers","volume":"132","author":"Stepulak","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.phrs.2020.104786_bib0445","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng1148","article-title":"Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia","volume":"34","author":"Pollock","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2020.104786_bib0450","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","article-title":"Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma","volume":"67","author":"Namkoong","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0455","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10549-011-1624-x","article-title":"Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer","volume":"132","author":"Speyer","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2020.104786_bib0460","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/1078-0432.CCR-04-1912","article-title":"Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance","volume":"11","author":"Chang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuropharm.2016.02.011","article-title":"Metabotropic glutamate receptors in cancer","volume":"115","author":"Yu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2020.104786_bib0470","doi-asserted-by":"crossref","first-page":"82","DOI":"10.18632\/oncoscience.11","article-title":"Melanoma brain colonization involves the emergence of a brain-adaptive phenotype","volume":"1","author":"Nygaard","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.phrs.2020.104786_bib0475","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1523\/JNEUROSCI.2180-07.2007","article-title":"Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation","volume":"27","author":"Ishiuchi","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib0480","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0005-2736(01)00338-8","article-title":"Human cystine\/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells","volume":"1512","author":"Kim","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2020.104786_bib0485","first-page":"485","article-title":"The role of GABA-ergic system in carcinogenesis","volume":"57","author":"Szczaurska","year":"2003","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.phrs.2020.104786_bib0490","first-page":"171","article-title":"GABA\u2019s control of stem and cancer cell proliferation in adult neural and peripheral niches","volume":"24","author":"Young","year":"2009","journal-title":"Physiology (Bethesda.)"},{"key":"10.1016\/j.phrs.2020.104786_bib0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01294790","article-title":"GABA binding sites: their density, their affinity to muscimol and their behaviour against neuroactive steroids in human gliomas of different degrees of malignancy","volume":"96","author":"Jussofie","year":"1994","journal-title":"J. Neural Transm. (Vienna, Austria)"},{"key":"10.1016\/j.phrs.2020.104786_bib0500","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1073\/pnas.1322098111","article-title":"Human breast cancer metastases to the brain display GABAergic properties in the neural niche","volume":"111","author":"Neman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2020.104786_bib0505","doi-asserted-by":"crossref","first-page":"e3383","DOI":"10.1371\/journal.pone.0003383","article-title":"Mutants of GABA Transaminase (POP2) Suppress the Severe Phenotype of succinic semialdehyde dehydrogenase (ssadh) Mutants in Arabidopsist","volume":"3","author":"Ludewig","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.104786_bib0510","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00005072-199703000-00003","article-title":"Action potential-generating cells in human glioblastomas","volume":"56","author":"Labrakakis","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0515","first-page":"1","article-title":"Ion channels in brain metastasis","author":"Klumpp","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib0520","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/590249","article-title":"Ion channels in glioblastoma","volume":"2011","author":"Molenaar","year":"2011","journal-title":"ISRN Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00232-005-0781-4","article-title":"Ion channels and cancer","volume":"205","author":"Kunzelmann","year":"2005","journal-title":"Membr. Biol."},{"key":"10.1016\/j.phrs.2020.104786_bib0530","doi-asserted-by":"crossref","first-page":"C255","DOI":"10.1152\/ajpcell.00047.2011","article-title":"Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer","volume":"301","author":"Becchetti","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.phrs.2020.104786_bib0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002329900135","article-title":"Potassium channels, proliferation and G1 progression","volume":"154","author":"Wonderlin","year":"1996","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.phrs.2020.104786_bib0540","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cancers7020813","article-title":"Voltage-gated ion channels in cancer cell proliferation","volume":"7","author":"Rao","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2020.104786_bib0545","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1523\/JNEUROSCI.3825-10.2011","article-title":"Bradykinin promotes the chemotactic invasion of primary brain tumors","volume":"31","author":"Montana","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib0550","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tins.2012.05.001","article-title":"Unique biology of gliomas: challenges and opportunities","volume":"35","author":"Watkins","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib0555","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjc.6602775","article-title":"hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines","volume":"93","author":"Masi","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0560","first-page":"1","article-title":"Overexpression of Eag1 potassium channels in clinical tumours","volume":"13","author":"Hemmerlein","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0565","series-title":"hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers, 2015","author":"Lastraioli","year":"2015"},{"key":"10.1016\/j.phrs.2020.104786_bib0570","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/0008-5472.CAN-03-2360","article-title":"herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells","volume":"64","author":"Lastraioli","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0575","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1746-1596-5-78","article-title":"The Eag potassium channel as a new prognostic marker in ovarian cancer","volume":"5","author":"Asher","year":"2010","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.phrs.2020.104786_bib0580","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1054\/bjoc.2000.1497","article-title":"HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium","volume":"83","author":"Cherubini","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0585","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/sj.leu.2402572","article-title":"HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors","volume":"16","author":"Pillozzi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2020.104786_bib0590","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1091\/mbc.e04-10-0940","article-title":"Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling","volume":"16","author":"Cherubini","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.phrs.2020.104786_bib0595","doi-asserted-by":"crossref","first-page":"17157","DOI":"10.3390\/ijms140817157","article-title":"Molecular interactions in the development of brain metastases","volume":"14","author":"Martinez","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib0600","doi-asserted-by":"crossref","first-page":"36234","DOI":"10.1074\/jbc.M801830200","article-title":"Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors","volume":"283","author":"Downie","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.104786_bib0605","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1471-4159.2008.05615.x","article-title":"Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation","volume":"107","author":"Olsen","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.104786_bib0610","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1528-1167.2010.02592.x","article-title":"Potassium channel activity and glutamate uptake are impaired in astrocytes of seizure-susceptible DBA\/2 mice","volume":"51","author":"Inyushin","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1083\/jcb.201404136","article-title":"Targeting potassium channels in cancer","volume":"206","author":"Huang","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2020.104786_bib0620","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.onc.1210712","article-title":"A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells","volume":"27","author":"Williams","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2020.104786_bib0625","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/glia.20574","article-title":"Role of Kir4.1 channels in growth control of glia","volume":"55","author":"Higashimori","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2020.104786_bib0630","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1073\/pnas.0708044105","article-title":"The \u03b19\u03b21 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel","volume":"105","author":"deHart","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2020.104786_bib0635","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/0008-5472.CAN-09-2654","article-title":"Receptor channel TRPC6 is a key mediator of notch-driven glioblastoma growth and invasiveness","volume":"70","author":"Chigurupati","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0640","series-title":"Transcr. Gene Regul. Heal. Dis.","first-page":"167","article-title":"Chapter five \u2013 regulation of gene transcription following stimulation of transient receptor potential (TRP) channels","author":"Thiel","year":"2018"},{"key":"10.1016\/j.phrs.2020.104786_bib0645","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/jnci\/djq217","article-title":"Essential role of TRPC6 channels in G2\/M phase transition and development of human glioma","volume":"102","author":"Ding","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2020.104786_bib0650","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/neuonc\/nop028","article-title":"Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex","volume":"12","author":"de Groot","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0655","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.pjnns.2018.06.001","article-title":"Brain tumor related-epilepsy","volume":"52","author":"Goldstein","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.phrs.2020.104786_bib0660","article-title":"Cl- and K+ channels and their role in primary brain tumour biology","volume":"329","author":"Turner","year":"2014","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.phrs.2020.104786_bib0665","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4161\/cc.6.13.4357","article-title":"Cytoplasmic volume condensation is an integral part of mitosis","volume":"6","author":"Habela","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phrs.2020.104786_bib0670","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1523\/JNEUROSCI.1897-08.2008","article-title":"ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells","volume":"28","author":"Habela","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib0675","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/onc.2013.187","article-title":"Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent","volume":"33","author":"Davis","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2020.104786_bib0680","first-page":"1265","article-title":"Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells","volume":"31","author":"Restrepo-Angulo","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0685","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ijc.23894","article-title":"Nicotine induces cell proliferation, invasion and epithelial- mesenchymal transition in a variety of human cancer cell lines","volume":"124","author":"Dasgupta","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0690","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-811X-6-10","article-title":"Extravasation of leukocytes in comparison to tumor cells","volume":"6","author":"Strell","year":"2008","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phrs.2020.104786_bib0695","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain metastasis: unique challenges and open opportunities","volume":"1867","author":"Lowery","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0700","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nm.3303","article-title":"Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS","volume":"19","author":"Bittner","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2020.104786_bib0705","first-page":"245","article-title":"Dissection of the process of brain metastasis reveals targets and mechanisms for molecular-based intervention","volume":"13","author":"Weidle","year":"2016","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.phrs.2020.104786_bib0710","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00424-015-1784-3","article-title":"Kv10.1 K(+) channel: from physiology to cancer","volume":"468","author":"Ouadid-Ahidouch","year":"2016","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.phrs.2020.104786_bib0715","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00280-011-1569-0","article-title":"Epilepsy in the cancer patient","volume":"67","author":"Kargiotis","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0720","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.cco.0000142075.75591.02","article-title":"Palliative care in patients with primary brain tumors","volume":"16","author":"Taillibert","year":"2004","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0725","first-page":"365","article-title":"Mutating Our Understanding of Brain Tumors and Seizures: Entrez IDH","author":"Lee","year":"2017","journal-title":"Curr. Lit. Clin. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib0730","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.2174\/138161207782360528","article-title":"Valproic acid as anti-cancer drug","volume":"13","author":"Michaelis","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2020.104786_bib0735","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1586\/14737140.2014.940329","article-title":"Could valproic acid be an effective anticancer agent? The evidence so far","volume":"14","author":"Brodie","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.phrs.2020.104786_bib0740","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2020.104786_bib0745","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12437","article-title":"Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics","volume":"133","author":"Gefroh-Grimes","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.phrs.2020.104786_bib0750","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/neuonc\/noq044","article-title":"Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide","volume":"12","author":"Bobustuc","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0755","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-017-0546-9","article-title":"In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells","volume":"36","author":"Rizzo","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0760","first-page":"255","article-title":"Case of tumour in the left hemisphere of the brain producing epilepsy with paralysis","volume":"42","author":"Gairdner","year":"1834","journal-title":"Edinburgh Med. Surg. J."},{"key":"10.1016\/j.phrs.2020.104786_bib0765","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3171\/2012.10.JNS12169","article-title":"Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme","volume":"118","author":"Guthrie","year":"2013","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.phrs.2020.104786_bib0770","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib0775","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11060-016-2191-0","article-title":"Does the choice of antiepileptic drug affect survival in glioblastoma patients?","volume":"129","author":"Knudsen-Baas","year":"2016","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0780","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s12094-018-1892-6","article-title":"Choice of antiepileptic drugs affects the outcome in cancer patients with seizures","volume":"20","author":"Cacho-Diaz","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0785","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11060-017-2660-0","article-title":"Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma","volume":"136","author":"Cardona","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0790","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/cncr.29439","article-title":"Survival benefit of Levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0795","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0800","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00280-015-2695-x","article-title":"Phase I trial of valproic acid and lenalidomide in patients with advanced cancer","volume":"75","author":"Bilen","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0805","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00105-016-3797-z","article-title":"Melanoma brain metastases: treatment options","volume":"67","author":"Rauschenberg","year":"2016","journal-title":"Hautarzt"},{"key":"10.1016\/j.phrs.2020.104786_bib0810","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-009-0069-0","article-title":"Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy","volume":"98","author":"Maschio","year":"2010","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0815","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2015.01.015","article-title":"The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2)","volume":"93","author":"Romermann","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2020.104786_bib0820","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2011.04.056","article-title":"The effect of topiramate on tumor-related angiogenesis and on the serum proteome of mice bearing Lewis lung carcinoma","volume":"663","author":"Ma","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0825","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2016.08.009","article-title":"Drug interaction between erlotinib and phenytoin for brain metastases in a patient with nonsmall cell lung cancer","volume":"101","author":"Ohgami","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0830","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-012-0802-y","article-title":"Seizure prophylaxis and melanoma brain metastases","volume":"108","author":"Goldlust","year":"2012","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0835","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0840","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10143-014-0538-6","article-title":"Treatment of epileptic seizures in brain tumors: a critical review","volume":"37","author":"Bauer","year":"2014","journal-title":"Neurosurg. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2020.104786_bib0845","article-title":"Antiepileptic drugs for preventing seizures in people with brain tumors","author":"Ratilal","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2020.104786_bib0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0180470","article-title":"Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center","volume":"12","author":"Maschio","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.104786_bib0855","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2020.104786_bib0860","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1528-1167.2006.01132.x","article-title":"Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission","volume":"48","author":"Yang","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib0865","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0870","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ijrobp.2011.06.051","article-title":"Levetiracetam sensitizes glioblastoma multiforme cells to temozolomide plus radiation therapy","volume":"81","author":"Tandle","year":"2011","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.phrs.2020.104786_bib0880","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JOP.2017.025536","article-title":"Treatment of glioblastoma","volume":"13","author":"Nam","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.phrs.2020.104786_bib0885","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1158\/0008-5472.CAN-07-5312","article-title":"Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter","volume":"67","author":"Alonso","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0890","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fonc.2012.00098","article-title":"The strategy for enhancing temozolomide against malignant glioma","volume":"2","author":"Nakada","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0895","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1134\/S1819712416040073","article-title":"Tumor-inhibition effect of levetiracetam in combination with temozolomide in glioblastoma cells","volume":"11","author":"Marutani","year":"2017","journal-title":"Neurochem. J."},{"key":"10.1016\/j.phrs.2020.104786_bib0900","article-title":"Antitumor effect of levetiracetam combined with temozolomide in glioma cell lines","volume":"35","author":"Chen","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0905","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217393","article-title":"Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam","volume":"2016","author":"Peddi","year":"2016","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.phrs.2020.104786_bib0910","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.clineuro.2011.05.007","article-title":"Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage","volume":"113","author":"Mink","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.phrs.2020.104786_bib0915","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11060-012-0836-1","article-title":"Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy","volume":"108","author":"Simo","year":"2012","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0920","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib0925","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0006-8993(81)90828-3","article-title":"Effect of valproic acid on [3H]diazepam and [3H]dihydropicrotoxinin binding sites at the benzodiazepine-GABA receptor-ionophore complex","volume":"223","author":"Ticku","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0930","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0304-3940(84)90534-2","article-title":"Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlation to pharmacological effects","volume":"47","author":"L\u00f6scher","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2020.104786_bib0935","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(25)13076-0","article-title":"A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats","volume":"277","author":"Rohlfs","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2020.104786_bib0940","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.phrs.2020.104786_bib0945","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","article-title":"Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture","volume":"237","author":"McLean","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2020.104786_bib0950","first-page":"17","article-title":"Pharmacology of valproate","volume":"37","author":"Owens","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.phrs.2020.104786_bib0955","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2020.104786_bib0960","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.104786_bib0965","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0970","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1124\/mol.105.014167","article-title":"Rational development of histone deacetylase inhibitors as anticancer agents: a review","volume":"68","author":"Acharya","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0975","first-page":"237","article-title":"Histone deacetylase inhibitors as novel anticancer therapeutics","author":"Walkinshaw","year":"2008","journal-title":"DRUG Dev. Contemp. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib0980","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/taap.1999.8770","article-title":"New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta)","volume":"160","author":"Lampen","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib0985","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"110","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib0990","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(85)90207-0","article-title":"Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin","volume":"347","author":"Regan","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2020.104786_bib0995","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0736-5748(97)00019-1","article-title":"Valproic acid suppresses G1 phase-dependent sialylation of a 65kDa glycoprotein in the C6 glioma cell cycle","volume":"15","author":"Bacon","year":"1997","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib1000","first-page":"3585","article-title":"Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro","volume":"18","author":"Knupfer","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib1005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2867-6-2","article-title":"Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines","volume":"6","author":"Chavez-Blanco","year":"2006","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.phrs.2020.104786_bib1010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","article-title":"Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","volume":"85","author":"Das","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mce.2003.10.032","article-title":"Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7","volume":"213","author":"Olsen","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.phrs.2020.104786_bib1020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-006-9459-6","article-title":"Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells","volume":"105","author":"Hodges-Gallagher","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2020.104786_bib1025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1158\/1535-7163.MCT-05-0194","article-title":"In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates","volume":"4","author":"Marchion","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2020.104786_bib1030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/abbs\/gmr032","article-title":"Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment","volume":"43","author":"Ouyang","year":"2011","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.phrs.2020.104786_bib1035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1593\/neo.05823","article-title":"Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L\/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation","volume":"8","author":"Ziauddin","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.phrs.2020.104786_bib1040","doi-asserted-by":"crossref","first-page":"14666","DOI":"10.18632\/oncotarget.14716","article-title":"Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression","volume":"8","author":"Tseng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2020.104786_bib1045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib1050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.phrs.2020.104786_bib1055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/neuonc\/nop005","article-title":"Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines","volume":"12","author":"Fu","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib1060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-014-1713-x","article-title":"The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells","volume":"122","author":"Hosein","year":"2015","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1065","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.leukres.2011.02.021","article-title":"Hematologic improvement and response in elderly AML\/RAEB patients treated with valproic acid and low-dose Ara-C","volume":"35","author":"Corsetti","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.phrs.2020.104786_bib1070","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC \/ NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2020.104786_bib1075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.radonc.2015.10.009","article-title":"Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy","volume":"117","author":"Reddy","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/neuonc\/nou304","article-title":"Medical management of brain tumors and the sequelae of treatment","volume":"17","author":"Schiff","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"Suppl. 3","key":"10.1016\/j.phrs.2020.104786_bib1085","first-page":"S5","article-title":"Oxcarbazepine: mechanisms of action","volume":"35","author":"McLean","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib1090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.seizure.2010.11.019","article-title":"Effects of chronic treatment with valproate and oxcarbazepine on testicular development in rats","volume":"20","author":"Cansu","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.phrs.2020.104786_bib1095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7314\/APJCP.2014.15.1.199","article-title":"Possible anticancer activity of rosuvastatine, doxazosin, repaglinide and oxcarbazepin","volume":"15","author":"El Sharkawi","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.phrs.2020.104786_bib1100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-016-2056-6","article-title":"The effects of antiepileptic drugs on the growth of glioblastoma cell lines","volume":"127","author":"Lee","year":"2016","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0b013e32834a7e6f","article-title":"Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer","volume":"21","author":"Stettner","year":"2012","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.phrs.2020.104786_bib1110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2018.04.004","article-title":"Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: retrospective multicentre study in 285 Italian patients","volume":"390","author":"Rigamonti","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib1115","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.2174\/1381612823666171027130003","article-title":"Seizures and anticonvulsants in brain tumours: frequency, mechanisms and anti-epileptic management","volume":"23","author":"Vecht","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2020.104786_bib1120","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3171\/2013.1.JNS12397","article-title":"Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article","volume":"118","author":"Saria","year":"2013","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.phrs.2020.104786_bib1125","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.7717\/peerj.114","article-title":"Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis","volume":"1","author":"Sawh","year":"2013","journal-title":"PeerJ."},{"key":"10.1016\/j.phrs.2020.104786_bib1130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yebeh.2017.05.031","article-title":"Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: a prospective explorative study with a historical control group","volume":"73","author":"Maschio","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.phrs.2020.104786_bib1135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semradonc.2015.02.009","article-title":"Clinical management of seizures in patients with low-grade glioma","volume":"25","author":"Piotrowski","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1140","first-page":"89","article-title":"Safety and efficacy of zonisamide in patients with epilepsy: a post-marketing surveillance study","author":"Lee","year":"1992","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.phrs.2020.104786_bib1145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/WNF.0000000000000218","article-title":"Zonisamide in brain tumor-related epilepsy: an observational pilot study","volume":"40","author":"Maschio","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib1150","doi-asserted-by":"crossref","first-page":"P2.057","DOI":"10.1212\/WNL.86.16_supplement.P2.057","article-title":"Perampanel as an adjunctive treatment in 3 patients with Glioblastoma Multiforme (GBM) with refractory seizures (P2.057)","volume":"86","author":"Espinosa","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2020.104786_bib1155","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.21873\/anticanres.12737","article-title":"Seizures and tumor progression in glioma patients with uncontrollable epilepsy treated with perampanel","volume":"36","author":"Izumoto","year":"2018","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.phrs.2020.104786_bib1160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/00207454.2018.1555160","article-title":"Perampanel in patients with brain tumour-related epilepsy in real-life clinical practice: a retrospective analysis","volume":"129","author":"Maschio","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.phrs.2020.104786_bib1165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib1170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2015.04.011","article-title":"Lacosamide reduces HDAC levels in the brain and improves memory: potential for treatment of Alzheimer\u2019s disease","volume":"134","author":"Bang","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2020.104786_bib1175","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.biocel.2013.06.008","article-title":"Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4","volume":"45","author":"He","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2020.104786_bib1180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11060-012-1037-7","article-title":"MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression","volume":"112","author":"Chen","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10571-013-9927-6","article-title":"MicroRNA-107 inhibits U87 glioma stem cells growth and invasion","volume":"33","author":"Chen","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2020.104786_bib1190","first-page":"508","article-title":"Update on antiepileptic drugs 2019","volume":"25","author":"Abou-khalil","year":"2019","journal-title":"Contin. (MINNEAP MINN)"},{"key":"10.1016\/j.phrs.2020.104786_bib1195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(02)02341-5","article-title":"Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice","volume":"453","author":"Cuadrado","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104786_bib1200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.phrs.2020.104786_bib1205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0004-282X2008000400007","article-title":"Association of lamotrigine and valproate in refractory epilepsies of children and adolescents","volume":"66","author":"Grisotto","year":"2008","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.phrs.2020.104786_bib1210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/1541-7786.MCR-17-0662","article-title":"FoxO3a mediates the inhibitory effects of the antiepileptic drug lamotrigine on breast Cancer growth","volume":"16","author":"Pellegrino","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib1215","first-page":"1","article-title":"AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro","volume":"14","author":"Bergner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.104786_bib1220","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.lfs.2005.01.003","article-title":"Carbamazepine is an inhibitor of histone deacetylases","volume":"76","author":"Beutler","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2020.104786_bib1225","first-page":"967","article-title":"Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells","volume":"25","author":"Meng","year":"2006","journal-title":"Ai Zheng"},{"key":"10.1016\/j.phrs.2020.104786_bib1230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/nop\/npu010","article-title":"Time to focus on brain tumor-related epilepsy trials","author":"Gallagher","year":"2014","journal-title":"Neuro-Oncology Pract."},{"key":"10.1016\/j.phrs.2020.104786_bib1235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-014-0277-x","article-title":"The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis","volume":"14","author":"Nelson","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2020.104786_bib1240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/epi.13267","article-title":"Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action","volume":"57","author":"Nicolas","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2020.104786_bib1245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13104-019-4103-9","article-title":"High dose gabapentin does not alter tumor growth in mice but reduces arginase activity and increases superoxide dismutase, IL \u2011 6 and MCP \u2011 1 levels in Ehrlich ascites","volume":"12","author":"Leal","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.phrs.2020.104786_bib1250","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2020.104786_bib1255","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Glantz","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2020.104786_bib1260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clineuro.2018.09.019","article-title":"The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis","volume":"174","author":"Lu","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.phrs.2020.104786_bib1265","first-page":"1186","article-title":"Valproic acid in patients with glioma: a small review","volume":"2","author":"Cacho-Diaz","year":"2017","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1270","first-page":"309","article-title":"Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer","volume":"5","author":"Baker","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2020.104786_bib1275","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","article-title":"Interactions between antiepileptic and chemotherapeutic drugs","volume":"2","author":"Vecht","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib1280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1008331708395","article-title":"Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity","volume":"12","author":"Bourg","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2020.104786_bib1285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s004150050191","article-title":"Clinical management of brain metastasis","volume":"245","author":"Vecht","year":"1998","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib1290","first-page":"2411","article-title":"Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes","volume":"83","author":"Liddle","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2020.104786_bib1295","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003088-200746040-00001","article-title":"The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2020.104786_bib1300","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/ene.13375","article-title":"Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study","volume":"24","author":"Bedetti","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib1305","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00415-017-8463-6","article-title":"Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study","volume":"264","author":"Belcastro","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2020.104786_bib1310","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/neuonc\/nox161","article-title":"Phase I\/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874\/ABTC 02","volume":"20","author":"Galanis","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.phrs.2020.104786_bib1315","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.2174\/1381612823666171115101557","article-title":"Seizures and antiepileptic drugs: from pathophysiology to clinical practice","volume":"23","author":"\u00c7ar\u00e7ak","year":"2017","journal-title":"Curr. Pharm. Des."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820302851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820302851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:09:58Z","timestamp":1760911798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820302851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":263,"alternative-id":["S1043661820302851"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104786","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104786"}}